The fifth edition of the World Health Organization (WHO) histologic classification of thyroid neoplasms released in 2022 includes newly recognized tumor types, subtypes, and a grading system. Follicular cell-derived neoplasms are categorized into three families (classes): benign tumors, low-risk neoplasms, and malignant neoplasms. The terms “follicular nodular disease” and “differentiated high-grade thyroid carcinoma” are introduced to account for multifocal hyperplastic/neoplastic lesions and differentiated thyroid carcinomas with high-grade features, respectively. The term “Hürthle cells” is replaced with “oncocytic cells.” Invasive encapsulated follicular and cribriform morular variants of papillary thyroid carcinoma (PTC) are now redefined as distinct tumor types, given their different genetic alterations and clinicopathologic characteristics from other PTC subtypes. The term “variant” to describe a subclass of tumor has been replaced with the term “subtype.” Instead, the term “variant” is reserved to describe genetic alterations. A histologic grading system based on the mitotic count, necrosis, and/or the Ki67 index is used to identify high-grade follicular-cell derived carcinomas and medullary thyroid carcinomas. The 2022 WHO classification introduces the following new categories: “salivary gland-type carcinomas of the thyroid” and “thyroid tumors of uncertain histogenesis.” This review summarizes the major changes in the 2022 WHO classification and their clinical relevance.
Citations
Citations to this article as recorded by
Tumeurs de la thyroïde : nouveautés de la classification OMS 2022 Serge Guyétant, Myriam Decaussin Petrucci, Emmanuelle Leteurtre Annales de Pathologie.2024; 44(1): 5. CrossRef
Diagnostic Performance of [18F]TFB PET/CT Compared with Therapeutic Activity [131I]Iodine SPECT/CT and [18F]FDG PET/CT in Recurrent Differentiated Thyroid Carcinoma David Ventura, Matthias Dittmann, Florian Büther, Michael Schäfers, Kambiz Rahbar, Daniel Hescheler, Michael Claesener, Philipp Schindler, Burkhard Riemann, Robert Seifert, Wolfgang Roll Journal of Nuclear Medicine.2024; 65(2): 192. CrossRef
Clinicopathological features of differentiated thyroid carcinoma as predictors of the effects of radioactive iodine therapy Wen Liu, Beibei Jiang, Jingli Xue, Ruijing Liu, Yuqing Wei, Peifeng Li Annals of Diagnostic Pathology.2024; 69: 152243. CrossRef
Management of aggressive variants of papillary thyroid cancer Ying Ki Lee, Aleix Rovira, Paul V. Carroll, Ricard Simo Current Opinion in Otolaryngology & Head & Neck Surgery.2024; 32(2): 125. CrossRef
Artificial Intelligence Detected the Relationship Between Nuclear Morphological Features and Molecular Abnormalities of Papillary Thyroid Carcinoma Toui Nishikawa, Ibu Matsuzaki, Ayata Takahashi, Iwamoto Ryuta, Fidele Yambayamba Musangile, Kanako Sagan, Mizuki Nishikawa, Yurina Mikasa, Yuichi Takahashi, Fumiyoshi Kojima, Shin-ichi Murata Endocrine Pathology.2024; 35(1): 40. CrossRef
Review of the 2023 World Congress on Thyroid Cancer (WCTC 2023, London): is there light at the end of the tunnel for patients with neglected cancer? S.M. Cherenko INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2024; 19(8): 609. CrossRef
Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma Lindsay A. Bischoff, Ian Ganly, Laura Fugazzola, Erin Buczek, William C. Faquin, Bryan R. Haugen, Bryan McIver, Caitlin P. McMullen, Kate Newbold, Daniel J. Rocke, Marika D. Russell, Mabel Ryder, Peter M. Sadow, Eric Sherman, Maisie Shindo, David C. Shonk JAMA Otolaryngology–Head & Neck Surgery.2024; 150(3): 265. CrossRef
Malignancy in a Solitary Thyroid Nodule: A Retrospective Histopathological Evaluation Hassan Alzahrani International Journal of General Medicine.2024; Volume 17: 135. CrossRef
Pathologie thyroïdienne. Actualités et problèmes pratiques. Introduction Serge Guyétant Annales de Pathologie.2024; 44(2): 90. CrossRef
Diagnostic implication of thyroid spherules for cytological diagnosis of thyroid nodules Heeseung Sohn, Kennichi Kakudo, Chan Kwon Jung Cytopathology.2024; 35(3): 383. CrossRef
Aggressive Primary Thyroid Mucoepidermoid Carcinoma with Extensive Pulmonary Involvement Marius Mitrache, Dana Terzea, Anca Sirbu, Simona Fica Biomedicines.2024; 12(2): 285. CrossRef
Unravelling the role of long non-coding RNAs in modulating the Hedgehog pathway in cancer Shailendra Singh Chandel, Anurag Mishra, Gaurav Dubey, Ravindra Pal Singh, Mithilesh Singh, Mohit Agarwal, Himmat Singh Chawra, Neelima Kukreti Pathology - Research and Practice.2024; 254: 155156. CrossRef
Hürthle cell (Oncocytic) carcinoma – Is hemithyroidectomy enough? Taylor O. Julsrud, Trenton R. Foster, Robert A. Vierkant, Melanie L. Lyden, Travis J. McKenzie, Mabel Ryder, Benzon M. Dy Surgical Oncology Insight.2024; 1(1): 100010. CrossRef
Échographie des carcinomes thyroïdiens différenciés de souche folliculaire P.Y. Marcy, M. Tassart, J.G. Marchand, J. Sanglier, A. Bizeau, E. Ghanassia Journal d'imagerie diagnostique et interventionnelle.2024; 7(2): 54. CrossRef
Differentiating BRAF V600E- and RAS-like alterations in encapsulated follicular patterned tumors through histologic features: a validation study Chankyung Kim, Shipra Agarwal, Andrey Bychkov, Jen-Fan Hang, Agnes Stephanie Harahap, Mitsuyoshi Hirokawa, Kennichi Kakudo, Somboon Keelawat, Chih-Yi Liu, Zhiyan Liu, Truong Phan-Xuan Nguyen, Chanchal Rana, Huy Gia Vuong, Yun Zhu, Chan Kwon Jung Virchows Archiv.2024;[Epub] CrossRef
Cas no5. High-grade Tall cell papillary carcinoma Myriam Decaussin-Petrucci Annales de Pathologie.2024; 44(2): 114. CrossRef
Current and future of immunotherapy for thyroid cancer based on bibliometrics and clinical trials Ke Wang, Ying Zhang, Yang Xing, Hong Wang, Minghua He, Rui Guo Discover Oncology.2024;[Epub] CrossRef
Cas no6. Anaplastic thyroid carcinoma, epidermoid subtype Myriam Decaussin-Petrucci Annales de Pathologie.2024; 44(2): 120. CrossRef
Papillary Thyroid Carcinoma With Lymphoepithelial Features and Lacking Association With Epstein-Barr Virus (EBV): A Rare Case Ahmed Bendari, Saroja Devi Geetha, Reham Al-Refai, Xuelin Zhong, Sunder Sham, Manju Harshan Cureus.2024;[Epub] CrossRef
Clinical and morphological features and unsolved issues in diagnosis of aggressive forms of papillary thyroid carcinoma Denis V. Korotovsky, Sergey V. Sergiiko, Sergey A. Lukyanov Perm Medical Journal.2024; 41(1): 90. CrossRef
Finding possible diagnostic markers for differentiating benign and malignant thyroid tumors on example investigate of rheological properties1 I. Javakhishvili, T. Sanikidze, K. Mardaleishvili, N. Momtselidze, T. Urdulashvili, M. Mantskava, L. Prantl, F. Jung Clinical Hemorheology and Microcirculation.2024; : 1. CrossRef
Unraveling the Significance of DGCR8 and miRNAs in Thyroid Carcinoma Lia Rodrigues, Arnaud Da Cruz Paula, Paula Soares, João Vinagre Cells.2024; 13(7): 561. CrossRef
Management of Poorly Differentiated Thyroid Cancer and Differentiated High-Grade Thyroid Carcinoma Iram S. Alam, Kepal N. Patel Surgical Clinics of North America.2024;[Epub] CrossRef
What’s new in thyroid pathology 2024: updates from the new WHO classification and bethesda system Andrey Bychkov, Chan Kwon Jung Journal of Pathology and Translational Medicine.2024; 58(2): 98. CrossRef
Ultrasound–Histopathological Presentation of Thyroid and Ovary Lesions in Adolescent Patients with DICER1 Syndrome: Case Reports and Literature Overview Dominika Januś, Monika Kujdowicz, Konrad Kaleta, Kamil Możdżeń, Jan Radliński, Anna Taczanowska-Niemczuk, Aleksandra Kiszka-Wiłkojć, Marcin Maślanka, Wojciech Górecki, Jerzy B. Starzyk Children.2024; 11(4): 403. CrossRef
Surgical treatment of solid variant of papillary thyroid carcinoma: Fifteen-year experience of a tertiary center Katarina Tausanović, Marina Stojanović, Milan Jovanović, Boban Stepanović, Jovan Ilić, Sara Ivaniš, Vladan Živaljević Medicinska istrazivanja.2024; 57(1): 121. CrossRef
Critical appraisal of the WHO 2022 classification of thyroid cancer Mithraa Devi Sekar, Debasis Gochhait, Sadishkumar Kamalanathan Thyroid Research and Practice.2024; 20(1): 8. CrossRef
Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma Chan Kwon Jung, Shipra Agarwal, Jen-Fan Hang, Dong-Jun Lim, Andrey Bychkov, Ozgur Mete Endocrine Pathology.2023; 34(1): 1. CrossRef
The 5th edition of WHO classification of tumors of endocrine organs: changes in the diagnosis of follicular-derived thyroid carcinoma Fulvio Basolo, Elisabetta Macerola, Anello Marcello Poma, Liborio Torregrossa Endocrine.2023; 80(3): 470. CrossRef
Preoperative Risk Stratification of Follicular-patterned Thyroid Lesions on Core Needle Biopsy by Histologic Subtyping and RAS Variant-specific Immunohistochemistry Meejeong Kim, Sora Jeon, Chan Kwon Jung Endocrine Pathology.2023; 34(2): 247. CrossRef
Ultrasound evolution of parenchymal changes in the thyroid gland with autoimmune thyroiditis in children prior to the development of papillary thyroid carcinoma – a follow-up study Dominika Januś, Monika Kujdowicz, Małgorzata Wójcik, Anna Taczanowska-Niemczuk, Aleksandra Kiszka-Wiłkojć, Wojciech Górecki, Jerzy B. Starzyk Frontiers in Endocrinology.2023;[Epub] CrossRef
Papillary thyroid carcinoma with aggressive fused follicular and solid growth pattern: A unique histological subtype with high‐grade malignancy? Shin‐ichi Murata, Ibu Matsuzaki, Mitsuo Kishimoto, Naomi Katsuki, Toshinori Onishi, Mitsuyoshi Hirokawa, Fumiyoshi Kojima Pathology International.2023; 73(5): 207. CrossRef
Multi-Omics and Management of Follicular Carcinoma of the Thyroid Thifhelimbilu Emmanuel Luvhengo, Ifongo Bombil, Arian Mokhtari, Maeyane Stephens Moeng, Demetra Demetriou, Claire Sanders, Zodwa Dlamini Biomedicines.2023; 11(4): 1217. CrossRef
Molecular Genetics of Diffuse Sclerosing Papillary Thyroid Cancer Meshael Alswailem, Balgees Alghamdi, Anwar Alotaibi, Abeer Aljomiah, Hindi Al-Hindi, Avaniyapuram Kannan Murugan, Mohamed Abouelhoda, Yufei Shi, Ali S Alzahrani The Journal of Clinical Endocrinology & Metabolism.2023; 108(9): e704. CrossRef
Multifunctional Phase-Transition Nanoparticles for Effective Targeted Sonodynamic-Gene Therapy Against Thyroid Papillary Carcinoma Shihui Guan, Dengke Teng, Hui Wang, Qimeihui Wang, Xi Zhen, Guoqing Sui, Yang Wang, Lingyu Zhu, Yuanqiang Lin, Dan Jiao, Feng Guo International Journal of Nanomedicine.2023; Volume 18: 2275. CrossRef
Utilizing Dynamic Risk Stratification in Patients With Tall Cell Variant Papillary Thyroid Cancer David Zimmer, Gilman Plitt, Brandon Prendes, Jamie Ku, Natalie Silver, Eric Lamarre, Emrullah Yilmaz, Jessica Geiger, Christian Nasr, Lea El Hage, Mario Skugor, Shauna Cambpell, Shlomo Koyfman, Jacob Miller, Neil Woody, Katherine Heiden, Nikhil Joshi, Tar The Laryngoscope.2023; 133(9): 2430. CrossRef
Ultrasound, laboratory and histopathological insights in diagnosing papillary thyroid carcinoma in a paediatric population: a single centre follow-up study between 2000-2022 Dominika Januś, Małgorzata Wójcik, Anna Taczanowska-Niemczuk, Aleksandra Kiszka-Wiłkojć, Monika Kujdowicz, Małgorzata Czogała, Wojciech Górecki, Jerzy B. Starzyk Frontiers in Endocrinology.2023;[Epub] CrossRef
Medullary Thyroid Carcinoma: A Single Institute Experience Sonal Trivedi, T. Salahuddin, Mohamed Taher Mithi, Priyank Rathod, Arpit Bandi, Shashank J. Pandya, Mohit Sharma, Shailesh Patel, Vikas Warikoo, Ketul Puj, Abhijeet Salunkhe, Keval Patel, Shivam Pandya Indian Journal of Otolaryngology and Head & Neck Surgery.2023; 75(4): 2884. CrossRef
FNAC (Fine needle aspiration cytology) and histopathological correlation and reclassification of thyroid neoplasm in accordance with WHO classification 2022 Fareeda Joshi, Shreya Hegde Indian Journal of Pathology and Oncology.2023; 10(2): 132. CrossRef
Papillary thyroid carcinoma associated with non‑functioning parathyroid carcinoma with Warthin's tumor of the parotid gland: A case report and brief literature review Ari Abdullah, Aras Qaradakhy, Yadgar Saeed, Abdulwahid Salih, Seema Karim, Osama Ali, Shko Hassan, Shalaw Nasraldeen, Shvan Mohammed, Fahmi Kakamad Medicine International.2023;[Epub] CrossRef
Warthin-like papillary thyroid carcinoma: a case report and comprehensive review of the literature Abdel Mouhaymen Missaoui, Fatma Hamza, Wafa Belabed, Manel Mellouli, Mohamed Maaloul, Slim Charfi, Issam Jardak, Tahya Sellami-Boudawara, Nabila Rekik, Mohamed Abid Frontiers in Endocrinology.2023;[Epub] CrossRef
Reevaluating diagnostic categories and associated malignancy risks in thyroid core needle biopsy Chan Kwon Jung Journal of Pathology and Translational Medicine.2023; 57(4): 208. CrossRef
Cancer Predisposition Syndromes and Thyroid Cancer: Keys for a Short Two-Way Street Ioana Balinisteanu, Monica-Cristina Panzaru, Lavinia Caba, Maria-Christina Ungureanu, Andreea Florea, Ana Maria Grigore, Eusebiu Vlad Gorduza Biomedicines.2023; 11(8): 2143. CrossRef
Deep learning prediction model for central lymph node metastasis in papillary thyroid microcarcinoma based on cytology Wenhao Ren, Yanli Zhu, Qian Wang, Yuntao Song, Zhihui Fan, Yanhua Bai, Dongmei Lin Cancer Science.2023; 114(10): 4114. CrossRef
Cytology and Histology of Thyroid Nodules: Exploring Novel Insights in the Molecular Era for Enhanced Patient Management Beatrix Cochand-Priollet, Zahra Maleki Current Oncology.2023; 30(8): 7753. CrossRef
Agrin is a novel oncogenic protein in thyroid cancer Anna Adamiok‑Ostrowska, Małgorzata Grzanka, Barbara Czarnocka Oncology Letters.2023;[Epub] CrossRef
Analysis of Pathological Features of Thyroid Carcinoma in the Western Yunnan 身吾 王 Advances in Clinical Medicine.2023; 13(10): 15820. CrossRef
Insight of novel biomarkers for papillary thyroid carcinoma through multiomics Wei Liu, Junkan Zhu, Zhen Wu, Yongxiang Yin, Qiao Wu, Yiming Wu, Jiaojiao Zheng, Cong Wang, Hongyan Chen, Talal Jamil Qazi, Jun Wu, Yuqing Zhang, Houbao Liu, Jingmin Yang, Daru Lu, Xumin Zhang, Zhilong Ai Frontiers in Oncology.2023;[Epub] CrossRef
Identification of NIFTP-Specific mRNA Markers for Reliable Molecular Diagnosis of Thyroid Tumors So-Yeon Lee, Jong-Lyul Park, Kwangsoon Kim, Ja Seong Bae, Jae-Yoon Kim, Seon-Young Kim, Chan Kwon Jung Endocrine Pathology.2023; 34(3): 311. CrossRef
Somatostatin Receptor Type 2 and Thyroid-Stimulating Hormone Receptor Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and Treatment Andrea Gillis, Rui Zheng-Pywell, Chandler McLeod, Dezhi Wang, John M. Ness, Rachael Guenter, Jason Whitt, Tomas A. Prolla, Herbert Chen, Manuel Lora Gonzalez, Bart Rose, Ricardo V. Lloyd, Renata Jaskula-Sztul, Diana Lin Modern Pathology.2023; 36(12): 100332. CrossRef
Comparison of Treatment and Prognosis Between Follicular Variant
Papillary Thyroid Carcinoma and Classical Papillary Thyroid
Carcinoma Bing Zhang, Wenming Wu, Jinjing Liu, Zhou Liang, Liang Zong Hormone and Metabolic Research.2023; 55(12): 855. CrossRef
Sentinel lymph node mapping: current applications and future perspectives in thyroid carcinoma Isabella Merante Boschin, Loris Bertazza, Carla Scaroni, Caterina Mian, Maria Rosa Pelizzo Frontiers in Medicine.2023;[Epub] CrossRef
Utility of the Growth Differentiation Factor-15 in the Differential Diagnosis of Follicular-Patterned Lesions of the Thyroid on Cytopathologic and Histopathologic Samples Prasanna V Perumal, Neelaiah Siddaraju, Sunil K Saxena, Soundravally Rajendiran, Ramachandra V Bhat Cureus.2023;[Epub] CrossRef
Applications of machine and deep learning to thyroid cytology and histopathology: a review Greg Slabaugh, Luis Beltran, Hasan Rizvi, Panos Deloukas, Eirini Marouli Frontiers in Oncology.2023;[Epub] CrossRef
The Asian Thyroid Working Group, from 2017 to 2023 Kennichi Kakudo, Chan Kwon Jung, Zhiyan Liu, Mitsuyoshi Hirokawa, Andrey Bychkov, Huy Gia Vuong, Somboon Keelawat, Radhika Srinivasan, Jen-Fan Hang, Chiung-Ru Lai Journal of Pathology and Translational Medicine.2023; 57(6): 289. CrossRef
Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature Review Poupak Fallahi, Armando Patrizio, Giulio Stoppini, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Eugenia Balestri, Valeria Mazzi, Chiara Botrini, Gilda Varricchi, Salvatore Ulisse, Marco Ghionzoli, Alessandro Antonelli, Silvia Martina Ferrari Current Oncology.2023; 30(12): 10237. CrossRef
Construction and validation of a nomogram for predicting cervical lymph node metastasis in diffuse sclerosing variant of papillary thyroid carcinoma Xunyi Lin, Jiaxing Huo, Huan Zhang, Hang Su, Fenghua Zhang Langenbeck's Archives of Surgery.2023;[Epub] CrossRef
Canine follicular cell and medullary thyroid carcinomas: Immunohistochemical characterization Jana Jankovic, Eve Tièche, Martina Dettwiler, Kerstin Hahn, Stephanie Scheemaeker, Martin Kessler, Sylvie Daminet, Sven Rottenberg, Miguel Campos Veterinary Pathology.2023;[Epub] CrossRef
A 16-Year Single-Center Series of Trachea Resections for Locally Advanced Thyroid Carcinoma Julia I. Staubitz-Vernazza, Sina Schwind, Oana Lozan, Thomas J. Musholt Cancers.2023; 16(1): 163. CrossRef
Reprogramming of Cellular Metabolism and Its Therapeutic Applications in Thyroid Cancer Yuji Nagayama, Koichiro Hamada Metabolites.2022; 12(12): 1214. CrossRef
Developments to improve outcomes in thyroid surgery Thomas J. Musholt Innovative Surgical Sciences.2022; 7(3-4): 77. CrossRef
The relationship of the clinicopathological characteristics and treatment results of post-Chornobyl papillary thyroid microcarcinomas with the latency period and radiation exposure Tetiana Bogdanova, Serhii Chernyshov, Liudmyla Zurnadzhy, Tatiana I. Rogounovitch, Norisato Mitsutake, Mykola Tronko, Masahiro Ito, Michael Bolgov, Sergii Masiuk, Shunichi Yamashita, Vladimir A. Saenko Frontiers in Endocrinology.2022;[Epub] CrossRef
Meihua Jin, Eun Sook Kim, Bo Hyun Kim, Hee Kyung Kim, Hyon-Seung Yi, Min Ji Jeon, Tae Yong Kim, Ho-Cheol Kang, Won Bae Kim, Young Kee Shong, Mijin Kim, Won Gu Kim
Endocrinol Metab. 2020;35(3):618-627. Published online September 22, 2020
Background The study aimed to compare the prognostic value of the 4th edition of World Health Organization classification (WHO-2017) with the previous WHO classification (WHO-2004) for follicular thyroid carcinoma (FTC).
Methods This multicenter retrospective cohort study included 318 patients with FTC from five tertiary centers who underwent thyroid surgery between 1996 and 2009. We evaluated the prognosis of patients with minimally invasive (MI), encapsulated angioinvasive (EA), and widely invasive (WI) FTC according to WHO-2017. Further, we evaluated the proportion of variation explained (PVE) and Harrell’s C-index to compare the predictability of disease-free survival (DFS) and disease-specific survival (DSS).
Results In total, 227, 58, and 33 patients had MI-, EA-, and WI-FTC, respectively. During a median follow-up of 10.6 years, 46 (14.5%) patients had disease recurrence and 20 (6.3%) patients died from FTC. The 10-year DFS rates of patients with MI-, EA-, and WI-FTC were 91.1%, 78.2%, and 54.9%, respectively (P<0.001, PVE=7.1%, C-index=0.649). The corresponding 10-year DSS rates were 95.9%, 93.5%, and 73.5%, respectively (P<0.001, PVE=2.6%, C-index=0.624). The PVE and C-index values were higher using WHO-2017 than using WHO-2004 for the prediction of DFS, but not for DSS. In multivariate analysis, older age (P=0.02), gross extrathyroidal extension (ETE) (P=0.003), and distant metastasis (P<0.001) were independent risk factors for DSS.
Conclusion WHO-2017 improves the predictability of DFS, but not DSS, in patients with FTC. Distant metastasis, gross ETE and older age (≥55 years) were independent risk factors for DSS.
Citations
Citations to this article as recorded by
Association of Ultrasonography Features of Follicular Thyroid Carcinoma With Tumor Invasiveness and Prognosis Based on WHO Classification and TERT Promoter Mutation Myoung Kyoung Kim, Hyunju Park, Young Lyun Oh, Jung Hee Shin, Tae Hyuk Kim, Soo Yeon Hahn Korean Journal of Radiology.2024; 25(1): 103. CrossRef
Clinical Outcomes and Implications of Radioactive Iodine Therapy on Cancer-specific Survival in WHO Classification of FTC Genpeng Li, Ziyang Ye, Tao Wei, Jingqiang Zhu, Zhihui Li, Jianyong Lei The Journal of Clinical Endocrinology & Metabolism.2024;[Epub] CrossRef
Radioiodine whole body scan pitfalls in differentiated thyroid cancer Cristina Basso, Alessandra Colapinto, Valentina Vicennati, Alessandra Gambineri, Carla Pelusi, Guido Di Dalmazi, Elisa Lodi Rizzini, Elena Tabacchi, Arber Golemi, Letizia Calderoni, Stefano Fanti, Uberto Pagotto, Andrea Repaci Endocrine.2024;[Epub] CrossRef
The Prognostic Impact of Extent of Vascular Invasion in Follicular Thyroid Carcinoma David Leong, Anthony J. Gill, John Turchini, Michael Waller, Roderick Clifton‐Bligh, Anthony Glover, Mark Sywak, Stan Sidhu World Journal of Surgery.2023; 47(2): 412. CrossRef
TERT Promoter Mutation as a Prognostic Marker in Encapsulated Angioinvasive and Widely Invasive Follicular Thyroid Carcinomas Yasuhiro Ito, Takashi Akamizu Clinical Thyroidology.2023; 35(5): 202. CrossRef
Risk factors for death of follicular thyroid carcinoma: a systematic review and meta-analysis Ting Zhang, Liang He, Zhihong Wang, Wenwu Dong, Wei Sun, Ping Zhang, Hao Zhang Endocrine.2023; 82(3): 457. CrossRef
Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations Hyunju Park, Hyeong Chan Shin, Heera Yang, Jung Heo, Chang-Seok Ki, Hye Seung Kim, Jung-Han Kim, Soo Yeon Hahn, Yun Jae Chung, Sun Wook Kim, Jae Hoon Chung, Young Lyun Oh, Tae Hyuk Kim Modern Pathology.2022; 35(2): 186. CrossRef
Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8
Johan O Paulsson, Nima Rafati, Sebastian DiLorenzo, Yi Chen, Felix Haglund, Jan Zedenius, C Christofer Juhlin The Journal of Clinical Endocrinology & Metabolism.2021; 106(11): 3265. CrossRef
Clinicopathological Characteristics and Disease-Free Survival in Patients with Hürthle Cell Carcinoma: A Multicenter Cohort Study in South Korea Meihua Jin, Eun Sook Kim, Bo Hyun Kim, Hee Kyung Kim, Yea Eun Kang, Min Ji Jeon, Tae Yong Kim, Ho-Cheol Kang, Won Bae Kim, Young Kee Shong, Mijin Kim, Won Gu Kim Endocrinology and Metabolism.2021; 36(5): 1078. CrossRef